Ratings by Ladenburg Thalmann (Ahu Demir)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/2/2024 | Evaxion Biotech | EVAX | Upgrade | Buy (Neutral) |
3.23 (4.10) |
26.93% | Details | |
| 12/21/2023 | Evaxion Biotech | EVAX | Downgrade | Neutral (Buy) |
0.67 (4.10) |
511.94% | Details | |
| 11/27/2023 | Sonnet BioTherapeutics | SONN | New Coverage | Buy (N/A) |
1.41 (1.79) |
26.95% | Details | |
| 11/16/2023 | Advaxis | ADXS | Downgrade | Neutral (Buy) |
0.89 (0.60) |
-32.58% | Details | |
| 5/30/2023 | Ayala Pharmaceuticals | ADXS | Upgrade | Buy (Neutral) |
0.85 (0.60) |
-29.41% | Details | |
| 11/15/2022 | Evaxion Biotech | EVAX | Maintain | (N/A) |
|
Details | ||
| 11/8/2022 | Cellectar Biosciences | CLRB | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2022 | Peak Bio | PKBO | New Coverage | Buy (N/A) |
3.80 (2.56) |
-32.63% | Details | |
| 10/20/2022 | Ayala Pharmaceuticals | AYLA | Downgrade | Neutral (Buy) |
0.71 (0.50) |
-29.58% | Details | |
| 9/13/2022 | Ayala Pharmaceuticals | AYLA | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2022 | Immunocore Holdings | IMCR | New Coverage | Buy (N/A) |
49.98 (55.02) |
10.08% | Details | |
| 6/23/2022 | F-Star Therapeutics Inc. | FSTX | Downgrade | Neutral (Buy) |
3.98 (7.12) |
78.89% | Details | |
| 4/7/2022 | Cellectar Biosciences | CLRB | New Coverage | Buy (N/A) |
0.65 (3.32) |
410.77% | Details | |
| 3/1/2022 | Onconova Therapeutics | ONTX | New Coverage | Buy (N/A) |
1.62 (1.00) |
-38.27% | Details | |
| 11/18/2021 | F-Star Therapeutics Inc. | FSTX | New Coverage | Buy (N/A) |
6.16 (7.12) |
15.58% | Details | |
| 11/18/2021 | Cyclacel Pharmaceuticals | CYCC | New Coverage | Buy (N/A) |
4.67 (1.63) |
-65.1% | Details | |
| 9/23/2021 | Salarius Pharmaceuticals | SLRX | New Coverage | Buy (N/A) |
1.05 (0.47) |
-55.24% | Details | |
| 9/14/2021 | Aadi Bioscience Inc | AADI | New Coverage | Buy (N/A) |
27.96 (1.88) |
-93.28% | Details | |
| 8/19/2021 | Evaxion Biotech | EVAX | New Coverage | Buy (N/A) |
5.51 (4.10) |
-25.59% | Details | |
| 8/3/2021 | Immutep Limited | IMMP | New Coverage | Buy (N/A) |
3.46 (2.34) |
-32.37% | Details | |
| 7/13/2021 | Ayala Pharmaceuticals | AYLA | New Coverage | Buy (N/A) |
10.60 (0.50) |
-95.28% | Details |
